Induction of anterior chamber-associated immune deviation by corneal allografts placed in the anterior chamber

Investigative Ophthalmology and Visual Science

Volumn 38, Issue 13, 1997, Pages 2833-2843

  Yamada, Jun ^a   Streilein, J Wayne ^a  

^a SCHEPENS EYE RESEARCH INSTITUTE   (United States)

Author keywords

Anterior chamber associated immune deviation; Corneal transplantation; Delayed hypersensitivity; Immune privilege; Mice

Indexed keywords

ALLOGRAFT; ANIMAL CELL; ANIMAL TISSUE; ANTERIOR EYE CHAMBER; ARTICLE; BINDING SITE; CONTROLLED STUDY; CORNEA EPITHELIUM; CORNEA TRANSPLANTATION; DELAYED HYPERSENSITIVITY; HISTOPATHOLOGY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; ANTERIOR CHAMBER; CORNEA; CORNEAL TRANSPLANTATION; EPITHELIUM, CORNEAL; GRAFT SURVIVAL; HYPERSENSITIVITY, DELAYED; INFLAMMATION; MALE; MICE; MICE, INBRED BALB C; SERUM ALBUMIN, BOVINE; TRANSPLANTATION, HOMOLOGOUS;

EID: 0031470483     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Maumenee AE. The influence of donor-recipient sensitization on corneal grafts. Am J Ophthalmol. 1951; 34:142-152.
2. Williams KA, Coster DJ. Penetrating corneal transplantation in the inbred rat: A new model. Invest Ophthalmol Vis Sci. 1985;26:23-30.
3. Sonoda Y, Streilein JW. Orthotopic corneal transplantation in mice-evidence that the immunogenetic rules of rejection do not apply. Transplantation. 1992;54:694-704.
4. Sonoda Y, Streilein JW. Impaired cell-mediated immunity in mice bearing healthy orthotopic corneal allografts. J Immunol. 1993;150:1727-1734.
5. Streilein JW. Immune regulation and the eye: A dangerous compromise. FASEB J. 1987;1:199-208.
6. Niederkorn JY. Immune privilege and immune regulation in the eye. Adv Immunol. 1990;48:191-226.
7. Sonoda Y, Ksander B, Streilein JW. Evidence that active suppression contributes to the success of H-2-incompatible orthotopic corneal allografts in mice. Transplant Proc. 1993;25:1374-1376.
8. Sonoda Y, Sano Y, Ksander B, Streilein JW. Characterization of cell-mediated immune responses elicited by orthotopic corneal allografts in mice. Invest Ophthalmol Vis Sci. 1995;6:427-434.
9. Streilein JW, McCulley J, Niederkorn JY. Heterotopic corneal grafting in mice: A new approach to the study of corneal alloimmunity. Invest Ophthalmol Vis Sci. 1982;23:489-500.
10. Streilein JW, Toews GB, Bergstresser PR. Corneal allografts fail to express Ia antigens. Nature. 1979; 282:326-327.
11. Whitsett CF, Stulting RD. The distribution of HLA antigens on human corneal tissue. Invest Ophthalmol Vis Sci. 1984;25:519-524.
12. Treseler PA, Foulks GN, Sanfilippo F. The expression of HLA antigens by cells in the human cornea. Am J Ophthalmol. 1984;98:763-772.
13. Wang HM, Kaplan HJ, Chan WC, Johnson M. The distribution and ontogeny of MHC antigens in murine ocular tissue. Invest Ophthalmol Vis Sci. 1987;28:1383-1389.
14. Treseler PA, Sanfilippo F. The expression of major histocompatibility complex and leukocyte antigens by cells in the rat cornea. Transplantation. 1986;41:248-252.
15. Fujikawa LS, Colvin RB, Bhan AK, Fuller TC, Foster CS. Expression of HLA-A/B/C and -DR locus antigens on epithelial, stromal, and endothelial cells of the human cornea. Cornea. 1982;1:213-222.
16. She SC, Moticka EJ. Ability of intracamerally inoculated B- and T-cell enriched allogeneic lymphocytes to enhance corneal allograft survival. Intl Ophthalmol. 1993;17:l-7.
17. Okamoto S, Hara Y, Streilein JW. Induction of anterior chamber-associated immune deviation with lymphoreticular allogeneic cells. Transplantation. 1995; 59:377-381.
18. Wilbanks GA, Mammolenti M, Streilein JW. Studies on the induction of anterior chamber-associated immune deviation (ACAID). III. Induction of ACAID depends upon intraocular transforming growth factor-beta. Eur J Immunol. 1992;22:165-173.
19. Niederkorn J, Streilein JW, Shadduck JA. Deviant immune responses to allogeneic tumors injected intracamerally and subcutaneously in mice. Invest Ophthalmol Vis Sci. 1981;20:355-363.
20. Benson JL, Niederkorn JY. The presence of donorderived class II-positive cells abolishes immune privilege in the anterior chamber of the eye. Transplantation. 1991;51:834-838.
21. Matoba AY, Peeler JS, Niederkorn JY. T-cell subsets in the immune rejection of murine heterotopic corneal allografts. Invest Ophthalmol Vis Sci. 1986;27:1244-1254.
22. Chandler JW, Ray-Keil L, Gillette TE. Experimental corneal allograft rejection: Description of murine model and a new hypothesis of immunopathogenesis. Curr Eye Res. 1982;2:387-397.
23. Lafferty KJ, Prowse SJ, Simeonovic CJ, Warren HS. Immunobiology of tissue transplantation: A return to the passenger leukocyte concept. Ann Rev Immunol. 1983; 1:143-173.
24. Gillette TE, Chandler JW, Greiner JV. Langerhans cells of the ocular surface. Ophthalmology. 1982; 89:700-711.
25. Rodrigues MM, Rowden G, HackettJ, Bakos I. Langerhans cells in the normal conjunctiva and peripheral cornea of selected species. Invest Ophthalmol Vis Sci. 1981;21:759-765.
26. Bergstresser PR, Fletcher CR, Streilein JW. Surface densities of Langerhans cells in relation to rodent epidermal sites with special immunologic properties. J Invest Dermatol. 1980;74:77-80.
27. Shams NB, Sigel MM, DavisJF, Ferguson JG. Corneal epithelial cells produce thromboxane in response to interleukin 1 (IL-1). Invest Ophthalmol Vis Sci. 1986; 27:1543-1545.
28. Grabner G, Luger TA, Smolin G, Oppenheim JJ. Corneal epithelial cell-derived thymocyte-activating factor (CETAF). Invest Ophthalmol Vis Sci. 1982;23:757-763.
29. Benson JL, NiederkornJY. Interleukin-1 abrogates anterior chamber-associated immune deviation. Invest Ophthalmol Vis Sci. 1990;31:2123-2128.
30. Stulting RD, Waring GO, Bridges WZ, Cavanagh HD. Effect of donor epithelium on corneal transplant survival. Ophthalmology. 1988;95:803-812.
31. Streilein JW, Bradley D, Sano Y, Sonoda Y. Immuno-suppressive properties of tissues obtained from eyes with experimentally manipulated corneas. Invest Ophthalmol Vis Sci. 1996;37:413-424.
32. Wilbanks GA, Streilein JW. Studies on the induction of anterior chamber-associated immune deviation (ACAID). 1. Evidence that an antigen-specific, ACAID-inducing, cell-associated signal exists in the peripheral blood. J Immunol. 1991;146:2610-2617.
33. Wilbanks GA, Mammolenti M, Streilein JW. Studies on the induction of anterior chamber-associated immune deviation (ACAID). II. Eye-derived cells participate in generating blood-borne signals that induce ACAID. J Immunol. 1991;146:3018-3024.
34. Davies HS, Pollard SG, Calne RY. Soluble HLA antigens in the circulation of liver graft recipients. Transplantation. 1989;47:524-527.
35. DeVito-Haynes LD, Jankowska-Gan E, Sollinger HW, Knechtle SJ, Burlingham WJ. Monitoring of kidney and simultaneous pancreas-kidney transplantation rejection by release of donor-specific, soluble HLA class I. Hum Immunol. 1994;40:191-201.